Cardano(ADA)

$0.1748

▼ 0.39%24h

Price

$0.1748

24h Change

-0.39%

24h Range

$0.1714 – $0.1770

Market Cap

$6.52B

24h Volume

$222.2M

All-time high

$2.19

Price Chart▼ 1.27%

ADA News

All →

crypto-exchange

SecondFi to Return Assets After Cardano Wallet Exploit Following Forensic Review

SecondFi plans to return assets after a Cardano wallet exploit following forensic investigations and a final balance snapshot.

21d ago

crypto-exchange

SecondFi Suffers $2.4 Million Loss in Cardano Wallet Exploit

SecondFi lost $2.4 million after a Cardano wallet exploit, highlighting security risks in the crypto sector.

24d ago

blockchain-technology

SecondFi Secures 129 Million ADA After Cardano Wallet Exploit Traced to Address-Level Flaw

SecondFi traced a Cardano wallet exploit to an address-level issue and secured 129 million ADA after attackers drained funds from 374 addresses.

24d ago

Charles Hoskinson Highlights 'Midnight' as Key Catalyst for XRP's Next Growth Surge

Charles Hoskinson, the founder of Cardano and a well-known figure in the cryptocurrency space, recently commented on the future growth of Ripple's XRP token. He emphasized that a project called "Midnight" is crucial for XRP to enter its next phase of development and value appreciation. This statemen

38d ago

Price predictions 6/3: BTC, ETH, BNB, XRP, SOL, HYPE, DOGE, ZEC, ADA, XLM

Bitcoin is at risk of a drop below $65,000, but buyers are expected to mount a strong defense as the price nears the crucial $60,000 level. Read the full article at CoinTelegraph →

45d ago

Social Feed

ADA Press Releases

All →

JCN Newswire

LEQEMBI(R) Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference(R) (AAIC(R)) 2026

5d ago

ACN Newswire

The Inaugural Michelin Guide New Zealand Reveals 1 Two Michelin Stars, 14 One Michelin Star And 35 Bib Gourmands

12d ago

ACN Newswire

Hua Medicine Advances Glucose Homeostasis Platform at ADA 2026, Showcasing Dorzagliatin's Potential Across Metabolic Disease

39d ago

ACN Newswire

CMS's (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions

40d ago